Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A randomised, double-blind, placebo-controlled, parallel group study to investigate the anti-inflammatory and metabolic effects of rosiglitazone XR, 8mg once daily, in subjects with rheumatoid arthritis
rosiglitazone
ARA102198
NCT00379600
Arthritis, Rheumatoid
Phase 2
 
September 2013

Powered by ideaPoint, Inc.